Lixisenatide, a novel GLP ‐1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
Year: 2013
Type: review
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12253
Authors: G. B. Bolli, D. R. Owens
Institutions: University of Perugia, Swansea University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: lixisenatide, GLP-1 receptor agonists, type 2 diabetes, HbA1c, postprandial blood glucose, fasting blood glucose, gastric motility, insulin secretion, glucagon suppression, liraglutide, basal insulin, oral antidiabetic drugs, weight loss, gastrointestinal adverse effects, hypoglycemia risk
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W1978569902
